DK94781A - Fremgangsmaade til fremstilling af monoalkalimetalsalte af kulsyreanhydraseinhibitorer - Google Patents

Fremgangsmaade til fremstilling af monoalkalimetalsalte af kulsyreanhydraseinhibitorer

Info

Publication number
DK94781A
DK94781A DK94781A DK94781A DK94781A DK 94781 A DK94781 A DK 94781A DK 94781 A DK94781 A DK 94781A DK 94781 A DK94781 A DK 94781A DK 94781 A DK94781 A DK 94781A
Authority
DK
Denmark
Prior art keywords
anhydrase inhibitors
monoal
preparing
procedure
dibasic
Prior art date
Application number
DK94781A
Other languages
English (en)
Inventor
R L Smith
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK94781A publication Critical patent/DK94781A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94781A 1980-03-04 1981-03-03 Fremgangsmaade til fremstilling af monoalkalimetalsalte af kulsyreanhydraseinhibitorer DK94781A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12843980A 1980-03-04 1980-03-04

Publications (1)

Publication Number Publication Date
DK94781A true DK94781A (da) 1981-09-05

Family

ID=22435394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94781A DK94781A (da) 1980-03-04 1981-03-03 Fremgangsmaade til fremstilling af monoalkalimetalsalte af kulsyreanhydraseinhibitorer

Country Status (8)

Country Link
EP (1) EP0036351B1 (da)
JP (1) JPS56139417A (da)
AT (1) ATE11011T1 (da)
DE (1) DE3167999D1 (da)
DK (1) DK94781A (da)
GR (1) GR74437B (da)
IE (1) IE50901B1 (da)
PT (1) PT72600B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
US4483872A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma using n-substituted sulfonamides
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4542152A (en) * 1983-05-23 1985-09-17 Merck & Co., Inc. 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4585787A (en) * 1983-06-20 1986-04-29 Merck & Co., Inc. 5-[2(Or 3)-hydroxyphenylsulfonyl]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
DE3502962A1 (de) * 1985-01-30 1986-07-31 Merck Patent Gmbh, 6100 Darmstadt Komprimat
US5182264A (en) * 1986-03-07 1993-01-26 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
SG84487A1 (en) * 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
CA2294343A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860371A (en) * 1958-07-03 1961-02-01 Pfizer & Co C Di-sulfonamides and compositions containing them
GB851287A (en) * 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
NL7508856A (nl) * 1974-08-16 1976-02-18 Merck & Co Inc Werkwijze voor het bereiden van preparaten tegen hypertensie.
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
EP0033042B1 (en) * 1980-01-28 1984-08-22 Merck & Co. Inc. Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
DE3167999D1 (en) 1985-02-14
EP0036351A2 (en) 1981-09-23
IE50901B1 (en) 1986-08-06
GR74437B (da) 1984-06-28
PT72600B (en) 1982-12-20
ATE11011T1 (de) 1985-01-15
IE810429L (en) 1981-09-04
PT72600A (en) 1981-04-01
JPS56139417A (en) 1981-10-30
EP0036351B1 (en) 1985-01-02
EP0036351A3 (en) 1981-11-04

Similar Documents

Publication Publication Date Title
GR74437B (da)
ATE9059T1 (de) Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
SE8203887D0 (sv) Nya trombininhiberande foreningar
EP0031567A3 (en) Tetrapeptidesemicarbazide derivatives and their production and use
IE41374B1 (en) A composition for treating schizophrenia
ES2054609T3 (es) Procedimiento para la estabilizacion de la creatina-quinasa.
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ES495106A0 (es) Un metodo de preparar derivados de fenil-piperazina farma- ceuticamente activos
DK384485D0 (da) 1,6-naphthyridinderivater med kardilaterende virkning
ATE117313T1 (de) Stabile lösungen von rebeccamycinderivaten sowie deren herstellung.
AU536438B2 (en) Ophthalmic compositions
AU578252B2 (en) Flavene and thioflavene derivatives
EP0011092B1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
SE8502007L (sv) Cyklopentanderivat och sett for framstellning derav
GB1530848A (en) 2-(phenylalkylhydrazono)-propionic acid derivatives
DK159164C (da) Fremgangsmaade til fremstilling af humant leukocytinterferon i krystallinsk form
ES462982A1 (es) Un procedimiento para la preparacion de un derivado de acido 8-azaprostanoico.
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ES2037615A1 (es) Procedimiento de preparacion de acido 1,1-dioxo penicilanico, de sus esteres y sales.
JPS52100441A (en) Separation of racemic and optically active salts of p-hydroxyphenyl gl ycine with sulfonic acid derivatives
JPS5283710A (en) Sulfur-containing amino acid derivatives
FR2371923A1 (fr) Sels de lysine et d'arginine de l'acide 7-((cyanomethylthio)-acetamido)-3-(2-(5-methyl-1, 3, 4-thiadiazolyl)-thiomethyl)-d3-cepheme-4-carboxylique et procede pour leur preparation

Legal Events

Date Code Title Description
ATS Application withdrawn